Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 21 | 2024 | 2125 | 5.110 |
Why?
|
Placenta | 19 | 2024 | 1702 | 4.280 |
Why?
|
Fetal Development | 7 | 2020 | 766 | 1.970 |
Why?
|
Pregnancy | 68 | 2024 | 29742 | 1.850 |
Why?
|
Microglia | 5 | 2024 | 1349 | 1.840 |
Why?
|
Fetal Blood | 5 | 2023 | 1343 | 1.620 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2024 | 2496 | 1.420 |
Why?
|
Antibodies, Viral | 14 | 2024 | 3142 | 1.360 |
Why?
|
Serine Endopeptidases | 4 | 2021 | 1020 | 1.240 |
Why?
|
Fetus | 8 | 2024 | 1859 | 1.220 |
Why?
|
Infectious Disease Transmission, Vertical | 8 | 2022 | 1348 | 1.180 |
Why?
|
Metabolic Diseases | 4 | 2024 | 682 | 1.150 |
Why?
|
Lactation | 5 | 2023 | 397 | 1.130 |
Why?
|
Fetal Death | 3 | 2022 | 434 | 1.080 |
Why?
|
Amniotic Fluid | 6 | 2015 | 378 | 0.990 |
Why?
|
Pregnancy Complications | 6 | 2016 | 2942 | 0.870 |
Why?
|
Fetal Distress | 1 | 2022 | 39 | 0.810 |
Why?
|
Antibody Formation | 3 | 2022 | 1400 | 0.770 |
Why?
|
Psychological Tests | 1 | 2023 | 639 | 0.760 |
Why?
|
Pregnancy Trimester, Second | 7 | 2015 | 732 | 0.710 |
Why?
|
Obesity | 11 | 2024 | 12870 | 0.710 |
Why?
|
Macrophages | 4 | 2024 | 5737 | 0.710 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.710 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2016 | 3602 | 0.680 |
Why?
|
Specimen Handling | 2 | 2020 | 707 | 0.640 |
Why?
|
Infant, Newborn | 20 | 2024 | 26183 | 0.610 |
Why?
|
Female | 78 | 2024 | 390323 | 0.590 |
Why?
|
Postpartum Period | 4 | 2022 | 1167 | 0.590 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9404 | 0.500 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 463 | 0.500 |
Why?
|
Brain | 6 | 2024 | 26947 | 0.470 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1826 | 0.460 |
Why?
|
Immunity | 5 | 2022 | 998 | 0.460 |
Why?
|
Prosencephalon | 1 | 2016 | 305 | 0.460 |
Why?
|
Mothers | 3 | 2023 | 2189 | 0.410 |
Why?
|
Self Report | 1 | 2023 | 3714 | 0.400 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2012 | 52 | 0.400 |
Why?
|
Humans | 80 | 2024 | 758406 | 0.390 |
Why?
|
Patient Participation | 1 | 2020 | 1436 | 0.380 |
Why?
|
Sex Factors | 4 | 2024 | 10504 | 0.380 |
Why?
|
Phenols | 2 | 2012 | 514 | 0.380 |
Why?
|
Vacuum Curettage | 1 | 2011 | 45 | 0.370 |
Why?
|
Maternal Exposure | 2 | 2021 | 1045 | 0.360 |
Why?
|
Nervous System | 1 | 2014 | 543 | 0.360 |
Why?
|
Nuchal Translucency Measurement | 1 | 2011 | 59 | 0.360 |
Why?
|
Pregnancy, Multiple | 1 | 2011 | 215 | 0.340 |
Why?
|
Labor, Induced | 1 | 2011 | 151 | 0.330 |
Why?
|
Twins | 1 | 2011 | 339 | 0.330 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1842 | 0.330 |
Why?
|
Mental Health | 1 | 2023 | 3234 | 0.330 |
Why?
|
Databases, Genetic | 2 | 2015 | 1737 | 0.320 |
Why?
|
Vaccination | 6 | 2024 | 3355 | 0.320 |
Why?
|
Adult | 32 | 2024 | 219935 | 0.310 |
Why?
|
Pre-Eclampsia | 4 | 2016 | 1227 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3076 | 0.310 |
Why?
|
Puerperal Disorders | 3 | 2023 | 299 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3196 | 0.310 |
Why?
|
Abortion, Spontaneous | 3 | 2021 | 530 | 0.300 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15399 | 0.290 |
Why?
|
Immunoglobulin G | 5 | 2022 | 4540 | 0.290 |
Why?
|
Pandemics | 10 | 2023 | 8611 | 0.270 |
Why?
|
Neck | 1 | 2011 | 731 | 0.260 |
Why?
|
Nervous System Diseases | 1 | 2016 | 1647 | 0.260 |
Why?
|
Checklist | 2 | 2023 | 827 | 0.260 |
Why?
|
Abortion, Induced | 1 | 2011 | 460 | 0.240 |
Why?
|
Infant | 10 | 2024 | 36055 | 0.240 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2023 | 621 | 0.240 |
Why?
|
Hydrogen | 1 | 2024 | 171 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.220 |
Why?
|
Trophoblasts | 2 | 2021 | 224 | 0.220 |
Why?
|
MicroRNAs | 2 | 2016 | 3783 | 0.210 |
Why?
|
Progestins | 1 | 2024 | 302 | 0.200 |
Why?
|
Chorioamnionitis | 2 | 2022 | 156 | 0.200 |
Why?
|
Perinatology | 1 | 2022 | 62 | 0.200 |
Why?
|
Animals | 13 | 2024 | 167768 | 0.190 |
Why?
|
Hematologic Tests | 1 | 2022 | 238 | 0.180 |
Why?
|
Child | 15 | 2024 | 79818 | 0.180 |
Why?
|
Haptoglobins | 1 | 2021 | 167 | 0.170 |
Why?
|
Isoflurane | 1 | 2023 | 384 | 0.170 |
Why?
|
Parturition | 1 | 2023 | 446 | 0.170 |
Why?
|
Gestational Age | 5 | 2024 | 3565 | 0.170 |
Why?
|
Male | 19 | 2024 | 358747 | 0.170 |
Why?
|
Case-Control Studies | 8 | 2024 | 22029 | 0.160 |
Why?
|
Placenta Diseases | 1 | 2021 | 196 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1074 | 0.160 |
Why?
|
Cohort Studies | 6 | 2024 | 41256 | 0.160 |
Why?
|
Dexmedetomidine | 1 | 2023 | 316 | 0.160 |
Why?
|
Prospective Studies | 7 | 2024 | 54137 | 0.160 |
Why?
|
Diabetes, Gestational | 2 | 2024 | 1241 | 0.160 |
Why?
|
Disease Models, Animal | 4 | 2020 | 18119 | 0.150 |
Why?
|
Mice | 7 | 2024 | 81101 | 0.150 |
Why?
|
Adiponectin | 1 | 2024 | 1114 | 0.150 |
Why?
|
Perinatal Care | 1 | 2020 | 242 | 0.150 |
Why?
|
RNA, Messenger | 5 | 2024 | 12759 | 0.150 |
Why?
|
Hallucinogens | 1 | 2021 | 194 | 0.150 |
Why?
|
Prenatal Diagnosis | 2 | 2016 | 1264 | 0.140 |
Why?
|
Propofol | 1 | 2023 | 606 | 0.140 |
Why?
|
Protein Precursors | 1 | 2021 | 1133 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 483 | 0.140 |
Why?
|
Influenza A virus | 1 | 2020 | 457 | 0.140 |
Why?
|
Body Mass Index | 4 | 2024 | 12876 | 0.140 |
Why?
|
Maternal Health Services | 1 | 2022 | 455 | 0.140 |
Why?
|
Insulin Resistance | 2 | 2024 | 3941 | 0.140 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3774 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2022 | 1063 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 608 | 0.130 |
Why?
|
Autophagy | 1 | 2024 | 1322 | 0.130 |
Why?
|
Massachusetts | 3 | 2024 | 8823 | 0.130 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.130 |
Why?
|
Premature Birth | 1 | 2007 | 1771 | 0.130 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2016 | 110 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 766 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1617 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2057 | 0.120 |
Why?
|
Pregnancy Trimester, Third | 2 | 2020 | 582 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 436 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2144 | 0.120 |
Why?
|
Viral Load | 2 | 2020 | 3321 | 0.120 |
Why?
|
Histone Code | 1 | 2015 | 155 | 0.120 |
Why?
|
Cell Separation | 1 | 2020 | 1720 | 0.120 |
Why?
|
Breast Feeding | 1 | 2023 | 1355 | 0.120 |
Why?
|
RNA | 2 | 2015 | 2716 | 0.110 |
Why?
|
Pregnancy Outcome | 3 | 2011 | 2907 | 0.110 |
Why?
|
Retrospective Studies | 6 | 2024 | 80168 | 0.110 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2014 | 42 | 0.110 |
Why?
|
Amniocentesis | 1 | 2014 | 115 | 0.110 |
Why?
|
History, 21st Century | 1 | 2020 | 1573 | 0.110 |
Why?
|
Vertebral Artery Dissection | 1 | 2014 | 51 | 0.110 |
Why?
|
Fetofetal Transfusion | 1 | 2015 | 112 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 2 | 2012 | 1745 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 832 | 0.110 |
Why?
|
Principal Component Analysis | 1 | 2016 | 940 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 524 | 0.100 |
Why?
|
Term Birth | 1 | 2013 | 140 | 0.100 |
Why?
|
Computational Biology | 2 | 2015 | 3502 | 0.100 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22003 | 0.100 |
Why?
|
Fetal Weight | 1 | 2012 | 87 | 0.100 |
Why?
|
RNA, Viral | 1 | 2020 | 2836 | 0.100 |
Why?
|
Lipids | 1 | 2023 | 3326 | 0.100 |
Why?
|
Young Adult | 10 | 2024 | 58808 | 0.100 |
Why?
|
Child Development | 1 | 2024 | 2285 | 0.100 |
Why?
|
Phosphoproteins | 1 | 2020 | 2433 | 0.100 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2204 | 0.090 |
Why?
|
Chorion | 1 | 2011 | 114 | 0.090 |
Why?
|
Acute Disease | 2 | 2023 | 7225 | 0.090 |
Why?
|
Birth Weight | 2 | 2023 | 2097 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3020 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
Retinopathy of Prematurity | 1 | 2015 | 432 | 0.090 |
Why?
|
Neural Tube Defects | 1 | 2012 | 254 | 0.090 |
Why?
|
Neutrophils | 1 | 2022 | 3765 | 0.090 |
Why?
|
Amnion | 1 | 2011 | 197 | 0.080 |
Why?
|
Tachycardia, Supraventricular | 1 | 2002 | 273 | 0.080 |
Why?
|
Nucleic Acids | 1 | 2012 | 187 | 0.080 |
Why?
|
Catheter Ablation | 2 | 2003 | 2740 | 0.080 |
Why?
|
United States | 4 | 2022 | 72136 | 0.080 |
Why?
|
Organ Specificity | 1 | 2014 | 1955 | 0.080 |
Why?
|
Karyotyping | 1 | 2011 | 1171 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7583 | 0.080 |
Why?
|
Receptors, Fc | 2 | 2022 | 534 | 0.080 |
Why?
|
Hypertension | 1 | 2008 | 8499 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15785 | 0.080 |
Why?
|
Benzhydryl Compounds | 2 | 2012 | 900 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 551 | 0.080 |
Why?
|
Receptors, IgG | 2 | 2022 | 559 | 0.080 |
Why?
|
Headache | 1 | 2016 | 1248 | 0.080 |
Why?
|
Public Health | 1 | 2021 | 2658 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.080 |
Why?
|
Endocrine Disruptors | 1 | 2011 | 263 | 0.080 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2002 | 776 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2011 | 1539 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2001 | 0.070 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2007 | 30 | 0.070 |
Why?
|
Abortion, Habitual | 1 | 2007 | 61 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4342 | 0.070 |
Why?
|
Down Syndrome | 1 | 2015 | 892 | 0.070 |
Why?
|
Health Resources | 1 | 2003 | 931 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3754 | 0.070 |
Why?
|
Athletic Injuries | 1 | 2007 | 1211 | 0.070 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 908 | 0.070 |
Why?
|
Population Surveillance | 1 | 2007 | 2606 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4560 | 0.060 |
Why?
|
Fetal Growth Retardation | 1 | 2009 | 579 | 0.060 |
Why?
|
Child, Preschool | 6 | 2024 | 42062 | 0.060 |
Why?
|
Rats | 2 | 2023 | 23679 | 0.060 |
Why?
|
Receptors, Adiponectin | 1 | 2024 | 81 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8057 | 0.060 |
Why?
|
Pregnanolone | 1 | 2024 | 67 | 0.060 |
Why?
|
Seizures | 1 | 2016 | 2919 | 0.060 |
Why?
|
Cesarean Section | 1 | 2012 | 1385 | 0.060 |
Why?
|
Gases | 1 | 2023 | 203 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2022 | 193 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 24 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2008 | 867 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4373 | 0.050 |
Why?
|
Multigene Family | 1 | 2024 | 1076 | 0.050 |
Why?
|
Quality of Life | 2 | 2003 | 13285 | 0.050 |
Why?
|
Software | 1 | 2015 | 4415 | 0.050 |
Why?
|
Time | 2 | 2003 | 543 | 0.050 |
Why?
|
Pilot Projects | 1 | 2014 | 8553 | 0.040 |
Why?
|
Prevalence | 3 | 2020 | 15651 | 0.040 |
Why?
|
Time Factors | 1 | 2022 | 39872 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 604 | 0.040 |
Why?
|
Viremia | 1 | 2022 | 706 | 0.040 |
Why?
|
Adolescent | 7 | 2023 | 87892 | 0.040 |
Why?
|
Permeability | 1 | 2021 | 718 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5790 | 0.040 |
Why?
|
Progesterone | 1 | 2023 | 742 | 0.040 |
Why?
|
Health Care Costs | 1 | 2002 | 3245 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 638 | 0.040 |
Why?
|
Cytokines | 2 | 2023 | 7338 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2557 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1456 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 12945 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2021 | 1900 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 979 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2021 | 980 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 525 | 0.040 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2023 | 1988 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1075 | 0.030 |
Why?
|
Down-Regulation | 1 | 2024 | 2904 | 0.030 |
Why?
|
Risk Factors | 4 | 2021 | 73809 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1871 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2022 | 1468 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 17275 | 0.030 |
Why?
|
Anesthesia, General | 1 | 2023 | 1165 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 1933 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3563 | 0.030 |
Why?
|
Oligopeptides | 1 | 2021 | 1185 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1581 | 0.030 |
Why?
|
Trauma Severity Indices | 1 | 2007 | 478 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1386 | 0.030 |
Why?
|
HELLP Syndrome | 1 | 2014 | 40 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 13961 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2003 | 5103 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2118 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2022 | 1292 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3298 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2023 | 6013 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2346 | 0.030 |
Why?
|
New Mexico | 1 | 2003 | 83 | 0.030 |
Why?
|
Cell-Free System | 1 | 2013 | 340 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2014 | 335 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2023 | 8143 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3099 | 0.020 |
Why?
|
Platelet Activation | 1 | 2015 | 645 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2007 | 821 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3705 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1931 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2003 | 576 | 0.020 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 266 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18358 | 0.020 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2003 | 504 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 219568 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14641 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11070 | 0.020 |
Why?
|
Data Collection | 1 | 2007 | 3322 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9304 | 0.020 |
Why?
|
Hospitalization | 2 | 2020 | 10652 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14490 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1673 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3806 | 0.020 |
Why?
|
Heparin | 1 | 2014 | 1632 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2007 | 660 | 0.020 |
Why?
|
Dehydration | 1 | 2007 | 216 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10495 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20055 | 0.020 |
Why?
|
Blood Platelets | 1 | 2015 | 2475 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2015 | 3099 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12075 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2007 | 1829 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 4282 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8530 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2747 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 2115 | 0.010 |
Why?
|
Recurrence | 1 | 2003 | 8426 | 0.010 |
Why?
|
Echocardiography | 1 | 2003 | 4962 | 0.010 |
Why?
|
Stroke Volume | 1 | 2003 | 5460 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2007 | 1368 | 0.010 |
Why?
|
Anticoagulants | 1 | 2014 | 4777 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9650 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16534 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15225 | 0.010 |
Why?
|
Aged | 2 | 2021 | 168218 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13276 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39059 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15637 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10718 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36284 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2003 | 64378 | 0.000 |
Why?
|